124 related articles for article (PubMed ID: 22414730)
41. Endocytosis regulates TDP-43 toxicity and turnover.
Liu G; Coyne AN; Pei F; Vaughan S; Chaung M; Zarnescu DC; Buchan JR
Nat Commun; 2017 Dec; 8(1):2092. PubMed ID: 29233983
[TBL] [Abstract][Full Text] [Related]
42. Amyotrophic lateral sclerosis-linked mutant VAPB enhances TDP-43-induced motor neuronal toxicity.
Suzuki H; Matsuoka M
J Neurochem; 2011 Dec; 119(5):1099-107. PubMed ID: 21933185
[TBL] [Abstract][Full Text] [Related]
43. TDP-43 and ubiquitinated cytoplasmic aggregates in sporadic ALS are low frequency and widely distributed in the lower motor neuron columns independent of disease spread.
Bodansky A; Kim JM; Tempest L; Velagapudi A; Libby R; Ravits J
Amyotroph Lateral Scler; 2010 May; 11(3):321-7. PubMed ID: 20225928
[TBL] [Abstract][Full Text] [Related]
44. Splicing repression is a major function of TDP-43 in motor neurons.
Donde A; Sun M; Ling JP; Braunstein KE; Pang B; Wen X; Cheng X; Chen L; Wong PC
Acta Neuropathol; 2019 Nov; 138(5):813-826. PubMed ID: 31332509
[TBL] [Abstract][Full Text] [Related]
45. Early and selective reduction of NOP56 (Asidan) and RNA processing proteins in the motor neuron of ALS model mice.
Miyazaki K; Yamashita T; Morimoto N; Sato K; Mimoto T; Kurata T; Ikeda Y; Abe K
Neurol Res; 2013 Sep; 35(7):744-54. PubMed ID: 23582672
[TBL] [Abstract][Full Text] [Related]
46. Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex.
Dyer MS; Reale LA; Lewis KE; Walker AK; Dickson TC; Woodhouse A; Blizzard CA
J Neurochem; 2021 May; 157(4):1300-1315. PubMed ID: 33064315
[TBL] [Abstract][Full Text] [Related]
47. [Perampanel for Sporadic Amyotrophic Lateral Sclerosis].
Aizawa H; Kwak S
Brain Nerve; 2019 Nov; 71(11):1270-1278. PubMed ID: 31722313
[TBL] [Abstract][Full Text] [Related]
48. Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis.
Mori F; Tanji K; Miki Y; Wakabayashi K
J Neuropathol Exp Neurol; 2009 Nov; 68(11):1200-6. PubMed ID: 19816197
[TBL] [Abstract][Full Text] [Related]
49. Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 mice.
Spiller KJ; Khan T; Dominique MA; Restrepo CR; Cotton-Samuel D; Levitan M; Jafar-Nejad P; Zhang B; Soriano A; Rigo F; Trojanowski JQ; Lee VM
Neurobiol Dis; 2019 Apr; 124():133-140. PubMed ID: 30458231
[TBL] [Abstract][Full Text] [Related]
50. Alterations in subcellular localization of TDP-43 immunoreactivity in the anterior horns in sporadic amyotrophic lateral sclerosis.
Sasaki S; Takeda T; Shibata N; Kobayashi M
Neurosci Lett; 2010 Jul; 478(2):72-6. PubMed ID: 20447446
[TBL] [Abstract][Full Text] [Related]
51. Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis.
Diaz-Garcia S; Ko VI; Vazquez-Sanchez S; Chia R; Arogundade OA; Rodriguez MJ; Traynor BJ; Cleveland D; Ravits J
Acta Neuropathol; 2021 Dec; 142(6):985-1001. PubMed ID: 34618203
[TBL] [Abstract][Full Text] [Related]
52. Sporadic amyotrophic lateral sclerosis: Widespread multisystem degeneration with TDP-43 pathology in a patient after long-term survival on a respirator.
Nishihira Y; Tan CF; Toyoshima Y; Yonemochi Y; Kondo H; Nakajima T; Takahashi H
Neuropathology; 2009 Dec; 29(6):689-96. PubMed ID: 19170893
[TBL] [Abstract][Full Text] [Related]
53. A role for SUMOylation in the Formation and Cellular Localization of TDP-43 Aggregates in Amyotrophic Lateral Sclerosis.
Maurel C; Chami AA; Thépault RA; Marouillat S; Blasco H; Corcia P; Andres CR; Vourc'h P
Mol Neurobiol; 2020 Mar; 57(3):1361-1373. PubMed ID: 31728929
[TBL] [Abstract][Full Text] [Related]
54. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS.
Shiga A; Ishihara T; Miyashita A; Kuwabara M; Kato T; Watanabe N; Yamahira A; Kondo C; Yokoseki A; Takahashi M; Kuwano R; Kakita A; Nishizawa M; Takahashi H; Onodera O
PLoS One; 2012; 7(8):e43120. PubMed ID: 22900096
[TBL] [Abstract][Full Text] [Related]
55. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.
Hosaka T; Tsuji H; Kwak S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616
[TBL] [Abstract][Full Text] [Related]
56. Trauma, TDP-43, and amyotrophic lateral sclerosis.
Appel SH; Cwik VA; Day JW
Muscle Nerve; 2010 Dec; 42(6):851-2. PubMed ID: 21104858
[No Abstract] [Full Text] [Related]
57. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons.
Wang W; Li L; Lin WL; Dickson DW; Petrucelli L; Zhang T; Wang X
Hum Mol Genet; 2013 Dec; 22(23):4706-19. PubMed ID: 23827948
[TBL] [Abstract][Full Text] [Related]
58. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair.
Klim JR; Williams LA; Limone F; Guerra San Juan I; Davis-Dusenbery BN; Mordes DA; Burberry A; Steinbaugh MJ; Gamage KK; Kirchner R; Moccia R; Cassel SH; Chen K; Wainger BJ; Woolf CJ; Eggan K
Nat Neurosci; 2019 Feb; 22(2):167-179. PubMed ID: 30643292
[TBL] [Abstract][Full Text] [Related]
59. TDP-43 regulates endogenous retrovirus-K viral protein accumulation.
Manghera M; Ferguson-Parry J; Douville RN
Neurobiol Dis; 2016 Oct; 94():226-36. PubMed ID: 27370226
[TBL] [Abstract][Full Text] [Related]
60. Glutathione monoethyl ester prevents TDP-43 pathology in motor neuronal NSC-34 cells.
Chen T; Turner BJ; Beart PM; Sheehan-Hennessy L; Elekwachi C; Muyderman H
Neurochem Int; 2018 Jan; 112():278-287. PubMed ID: 28818672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
